Two Sigma Advisers
FEED

Two Sigma Advisers’s ENvue Medical Inc FEED Stock Holding History

Two Sigma Advisers’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9
Closed -$17K – 2600
2021
Q2 		$17K Buy
9
+2
+29% +$4.05K ﹤0.01% 2414
2021
Q1 		$15K Buy
+7
New +$17.9K ﹤0.01% 2525

Other funds holding FEED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AFS
Amtrust Financial Services New York $300M AUM 12.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Advisers's FEED Position: Q3 2021 in Review

Two Sigma Advisers sold out of ENvue Medical Inc (FEED) in Q3 2021, closing a stake of 9 shares — an estimated $17K sold.

Two Sigma Advisers first reported a position in FEED in Q1 2021 and held it in 2 quarters. The position peaked at $17K in Q2 2021. 19 funds tracked by Wall St. Rank hold FEED as of Q3 2021.

  • Two Sigma Advisers reported no remaining ENvue Medical Inc position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 9 ENvue Medical Inc shares in Q3 2021, an estimated $17K.
  • Two Sigma Advisers first reported a position in ENvue Medical Inc in Q1 2021 and held it in 2 quarters.
  • Two Sigma Advisers's ENvue Medical Inc position peaked at $17K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.